Placebo News and Research

RSS

Using antidepressant medication to treat people with depression and alcohol or drug abuse is beneficial

A meta-analysis of 14 studies involving patients with co-occurring depression and alcohol or drug abuse suggests that using antidepressant medication to treat people with these disorders is beneficial

6 Oct 2004

People prone to anger and aggression may be predisposed to develop an addiction to nicotine

People prone to anger and aggression may be predisposed to develop an addiction to nicotine compared with those who have happy, relaxed personalities, report NIDA-supported researchers.

6 Oct 2004

Vertigo sufferers may be suprised to learn just how easily curable their conditions are

A Baylor College of Medicine study on the most common form of vertigo illustrates that certain motions, not medications, can eliminate the vestibular problem’s disorienting effects.

5 Oct 2004

Testosterone may help men recover from a stroke

Testosterone – the hormone responsible for male sexual characteristics – may help him recover from a stroke, according to preliminary animal research at Saint Louis University

5 Oct 2004

Women who take the hormone therapy estrogen plus progestin have double the risk for venous thrombosis

Mary Cushman, M.D., M.Sc., of the University of Vermont, Colchester, Vt., and colleagues examined the effects of postmenopausal hormone therapy on VT in the presence of other thrombosis risk factors, such as age and obesity.

5 Oct 2004

Neurologists have discovered a drug application smart enough to alleviate orthostatic hypotension

Mayo Clinic neurologists have discovered a drug application smart enough to alleviate orthostatic hypotension -- problems with sinking blood pressure when standing up from a sitting position -- without the unwanted effect of also causing patients' blood pressure to soar when lying down.

5 Oct 2004

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease

A trial of beta-interferon-1a in inclusion-body myositis (IBM) has failed to find benefit from the drug in this disease. Beta-interferons counteract some of the activities of the immune system, which some experts believe is misguided in IBM.

5 Oct 2004

Minor depression is effectively treated with medication

Minor depression, an underdiagnosed and undertreated subset of major depressive disorder that affects upwards of 15 million Americans, can be effectively treated with a drug called a selective serotonin reuptake inhibitor (SSRI)

5 Oct 2004

$Analysis shows Teriparatide reduces fracture risk independent of bone turnover$

Analysis shows Teriparatide reduces fracture risk independent of bone turnover

Data presented yesterday at the 26th annual meeting of the American Society for Bone and Mineral Research (ASBMR) show that the ability of teriparatide to prevent fractures remained consistent regardless of pretreatment bone turnover status.

5 Oct 2004

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.

4 Oct 2004

Researchers investigate whether hormone therapy and two alternative herbal products can lessen memory in menopausal women

Researchers at the University of Illinois at Chicago are investigating whether hormone therapy and two alternative herbal products can lessen memory and other cognitive problems experienced by menopausal women.

4 Oct 2004

Reducing eosinophilic airway inflammation in severe asthma

Eosinophils are a type of white blood cell that constitute from 1 to 3 percent of the total white cell count. When foreign substances or infectious cells enter the body, lymphocytes and neutrophils attract eosinophils which release toxic substances that can destroy abnormal cells. Eosinophils function in allergic responses and in helping resist some infections.

4 Oct 2004

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.

4 Oct 2004

Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania

Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.

4 Oct 2004

Lycopene may be able to inhibit the growth of prostate tumours

A study by Dutch and German researchers has provided evidence that lycopene may be able to inhibit the growth of prostate tumours and that its effect may be enhanced if it is combined with vitamin E.

30 Sep 2004

Vitamin supplements not effective in protecting against gastro-intestinal cancer

A systematic review and meta-analysis (pooled analysis) of previously published randomised trials in this week’s issue of THE LANCET provides strong evidence that antioxidant supplements (such as vitamin supplements) are not effective in protecting against gastro-intestinal cancer.

30 Sep 2004

Draft Medicare plan to cover implantable defibrillators

The Centers for Medicare & Medicaid Services (CMS) today proposed to expand coverage of implantable cardioverter defibrillators (ICDs), a move expected to save thousands of lives a year.

29 Sep 2004

Study to test the effectiveness of anti-depressants in treating symptoms of Parkinson’s disease

While Parkinson’s disease typically brings to mind symptoms such as tremors and slow movement, researchers have found that nearly half of all Parkinson’s patients also suffer from depression. While it might seem natural that someone who has a disease such as Parkinson’s might become depressed, it’s not so simple, says neurologist Irene Richard, M.D., who leads the study.

27 Sep 2004

New drug application to market ramelteon for insomnia

Takeda Global Research & Development Center announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) to market ramelteon (TAK-375), its investigational drug for insomnia.

26 Sep 2004

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

AstraZeneca has announced important new data at the 4th European Stanley Foundation Conference on Bipolar Disorder, which show Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder and is also well-tolerated in this difficult to treat patient population.

26 Sep 2004

Placebo News and Research

Using antidepressant medication to treat people with depression and alcohol or drug abuse is beneficial

People prone to anger and aggression may be predisposed to develop an addiction to nicotine

Vertigo sufferers may be suprised to learn just how easily curable their conditions are

Testosterone may help men recover from a stroke

Women who take the hormone therapy estrogen plus progestin have double the risk for venous thrombosis

Neurologists have discovered a drug application smart enough to alleviate orthostatic hypotension

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease

Minor depression is effectively treated with medication

Analysis shows Teriparatide reduces fracture risk independent of bone turnover

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Researchers investigate whether hormone therapy and two alternative herbal products can lessen memory in menopausal women

Reducing eosinophilic airway inflammation in severe asthma

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania

Lycopene may be able to inhibit the growth of prostate tumours

Vitamin supplements not effective in protecting against gastro-intestinal cancer

Draft Medicare plan to cover implantable defibrillators

Study to test the effectiveness of anti-depressants in treating symptoms of Parkinson’s disease

New drug application to market ramelteon for insomnia

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News